| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,281 |
5,057 |
$182K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,010 |
1,713 |
$88K |
| 87428 |
|
1,213 |
1,046 |
$73K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
892 |
807 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
594 |
534 |
$12K |
| 99441 |
|
276 |
223 |
$7K |
| 99215 |
Prolong outpt/office vis |
90 |
87 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
460 |
313 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
270 |
233 |
$5K |
| 99442 |
|
59 |
56 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
75 |
64 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
83 |
54 |
$821.96 |
| 81025 |
|
42 |
36 |
$323.41 |
| 96127 |
|
72 |
70 |
$200.33 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
68 |
59 |
$46.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
50 |
39 |
$18.00 |
| 81002 |
|
27 |
24 |
$3.71 |
| 3725F |
|
1,252 |
1,044 |
$0.00 |
| 3078F |
|
2,256 |
1,836 |
$0.00 |
| 1160F |
|
984 |
802 |
$0.00 |
| 3077F |
|
673 |
558 |
$0.00 |
| 1159F |
|
710 |
591 |
$0.00 |
| 81003 |
|
60 |
47 |
$0.00 |
| 3080F |
|
350 |
292 |
$0.00 |
| 1036F |
|
1,586 |
1,283 |
$0.00 |
| 3074F |
|
2,608 |
2,122 |
$0.00 |
| 3079F |
|
1,457 |
1,206 |
$0.00 |
| 3075F |
|
925 |
763 |
$0.00 |
| 3008F |
|
605 |
486 |
$0.00 |